Resultats globals: 4 registres trobats en 0.03 segons.
Articles, 4 registres trobats
Articles 4 registres trobats  
1.
9 p, 1.6 MB Comparative Effectiveness Research in Localized Prostate Cancer : A 10-Year Follow-up Cohort Study / Garin, Olatz (Universitat Pompeu Fabra) ; Suárez, J.F. (Hospital Universitari de Bellvitge) ; Guedea, F. (Institut Català d'Oncologia) ; Pont, À. (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ; Pardo Cladellas, Yolanda (Universitat Autònoma de Barcelona) ; Goñi, A. (Institutu Onkologikoa) ; Mariño, Alfonso (Servicio de Oncología Radioterápica. Centro Oncológico de Galicia) ; Hervás, A. (Hospital Universitario Ramón y Cajal (Madrid)) ; Herruzo, I. (Hospital Regional Universitario Carlos Haya (Málaga)) ; Cabrera, Patricia (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Sancho-Pardo, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Ponce de León Roca, Javier (Institut d'Investigació Biomèdica Sant Pau) ; Macías Hernández, Víctor (Hospital Universitari i Politècnic La Fe (València)) ; Gutierrez, Cristina (Institut Català d'Oncologia) ; Castells, Manel (Hospital Universitari de Bellvitge) ; Ferrer, M. (Universitat Autònoma de Barcelona)
Purpose: Long-term comparative effectiveness research on localized prostate cancer treatments is scarce, and evidence is lacking especially for brachytherapy. The aim of this study was to assess the long-term impact of the side effects of radical prostatectomy, brachytherapy, and external radiation therapy on patients with localized prostate cancer at 10 years, using propensity score analyses. [...]
2021 - 10.1016/j.ijrobp.2020.12.032
International Journal of Radiation Oncology Biology Physics, Vol. 110 Núm. 3 (january 2021) , p. 718-726  
2.
8 p, 731.6 KB COVID-19's impact on care practice for alpha-1-antitrypsin deficiency patients / Calle Rubio, Myriam (Universidad Complutense de Madrid) ; López-Campos, José Luis (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Miravitlles, Marc (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Michel de la Rosa, Francisco Javier (Hospital de Donostia (Sant Sebastià, País Basc)) ; Hernández Pérez, José María (Hospital Universitario Nuestra Señora de Candelaria (Santa Cruz de Tenerife)) ; Montero Martínez, Carmen (Complejo Hospitalario Universitario de A Coruña) ; Montoro Ronsano, José Bruno (Hospital Universitari Vall d'Hebron) ; Casas-Maldonado, Francisco (Universidad de Granada) ; Rodríguez Hermosa, Juan Luis (Universidad Complutense de Madrid) ; Tabernero Huguet, Eva María (Hospital Universitario de Cruces (Barakaldo, País Basc)) ; Martínez Sesmero, José Manuel (Hospital Clínico San Carlos (Madrid)) ; Martínez Rivera, Carlos (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Callejas González, Francisco Javier (Hospital Complejo Universitario de Albacete) ; Torres Durán, María (Hospital Álvaro Cunqueiro (Vigo)) ; Universitat Autònoma de Barcelona
Patients with alpha-1 antitrypsin deficiency (AATD), commonly categorized as a rare disease, have been affected by the changes in healthcare management brought about by COVID-19. This study's aim was to identify the changes that have taken place in AATD patient care as a result of the COVID-19 pandemic in Spain and to propose experts' recommendations aimed at ensuring humanized and quality care for people with AATD in the post-pandemic situation. [...]
2023 - 10.1186/s12913-023-09094-3
BMC health services research, Vol. 23 (january 2023)  
3.
7 p, 942.3 KB Are continued policies of prioritizing native vascular access in patients on hemodialysis programs useful? / Ibáñez Pallarès, Sara (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ; Esteve Simó, Vicent (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ; Velescu, Alina (Hospital del Mar (Barcelona, Catalunya)) ; Tapia González, Irati (Universitat Autònoma de Barcelona. Departament de Medicina) ; Collado, S (Hospital del Mar (Barcelona, Catalunya)) ; Clará Velasco, Alberto (Hospital del Mar (Barcelona, Catalunya))
The guidelines recommend establishing native vascular access as opposed to prosthetic or catheter-based access despite information relating to its effectiveness being scarce from a patient-orientated perspective. [...]
2022 - 10.1111/1744-9987.13711
Therapeutic Apheresis and Dialysis, Vol 26 (2022) , p. 434-440  
4.
14 p, 1.0 MB Withdrawal of inhaled corticosteroids in COPD patients : Rationale and algorithms / Avdeev, S. (Clinical Department. Federal Pulmonology Research Institute. Federal Medical and Biological Agency of Russia) ; Aisanov, Z. (Department of Pulmonology. N.I. Pirogov Russian State National Research Medical University) ; Arkhipov, V. (Department of Clinical Pharmacology and Therapy. Russian Medical Academy of Continuous Professional Education) ; Belevskiy, A. (Department of Pulmonology. N.I. Pirogov Russian State National Research Medical University) ; Leshchenko, I. (Department of Phthisiology. Pulmonology and Thoracic Surgery. Ural State Medical University) ; Ovcharenko, S. (Department of Internal Diseases No.1. I.M. Sechenov First Moscow State Medical University) ; Shmelev, E. (Department of Differential Diagnostics. Federal Central Research Institute of Tuberculosis) ; Miravitlles, Marc. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Observational studies indicate that overutilization of inhaled corticosteroids (ICS) is common in patients with chronic obstructive pulmonary disease (COPD). Overprescription and the high risk of serious ICS-related adverse events make withdrawal of this treatment necessary in patients for whom the treatment-related risks outweigh the expected benefits. [...]
2019 - 10.2147/COPD.S207775
International journal of COPD, Vol. 14 (2019) , p. 1267-1280  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.